Take an online DNA test and you could be revealing far more than you realise
By Andelka Phillips,
The Conversation
| 01. 12. 2016
Untitled Document
Getting your DNA sequenced is now so cheap and easy that you don’t need to see a medical professional. A variety of online companies are offering direct-to-consumer (DTC) genetic tests for health or recreational purposes. These tests claim to detect a wide range of characteristics, from the risk of diseases such as breast cancer or Alzheimer’s or other conditions such as baldness, to specific talents or even romantic compatibility. But when you purchase one of these tests there’s a good chance you don’t know everything you’ve agreed to.
The DTC industry is new, growing and largely unregulated. As with many online companies, genetic testing firms rely on contracts to govern relations with their customers. Contracts are everywhere online, appearing as terms and conditions that you agree to with a click of a button or even just by browsing a website – and so they are known as clickwrap or browsewrap contracts.
Whether logging into Facebook or downloading a film, you’ve probably “signed” one of these contracts, perhaps without even realising. But do you have any...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Ryan Knutson and Jessica Mendoza, The Journal. | 03.27.2026
Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make one. In this final installment from The Journal’s investigation into the fringes of the fertility industry, WSJ’s Emily Glazer reports...
By Antonio Regalado, MIT Technology Review | 03.30.2026
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing.
In...
